Overall Winner: Hippocratic AI·65/ 100

Hippocratic AI vs Predible Health

In-depth comparison — valuation, funding, investors, founders & more

Winner
H
Hippocratic AI

🇺🇸 United States · Munjal Shah

Series BAI HealthcareEst. 2023

Valuation

N/A

Total Funding

$120M

65
Awaira Score65/100

50-200 employees

Full Hippocratic AI Profile →
P
Predible Health

🇮🇳 India · Sanjoy Paul

Series AAI HealthcareEst. 2017

Valuation

N/A

Total Funding

$5M

50
Awaira Score50/100

10-50 employees

Full Predible Health Profile →
🔬

Analyst Summary

Generated from real data · No AI hallucinations

Both Hippocratic AI and Predible Health compete directly in the AI Healthcare space, making this a head-to-head matchup within the same market segment. Hippocratic AI develops a safety-focused AI platform designed to address the global shortage of healthcare professionals by deploying AI agents that perform patient-facing healthcare communication tasks including care navigation, medication adherence outreach, chronic disease monitoring, and post-discharge follow-up. Predible Health develops AI software for radiology and medical imaging analysis, with a focus on automated CT scan interpretation for lung nodule detection, COVID-19 assessment, and liver segmentation.

Neither company has publicly disclosed a valuation at this time. On the funding side, Hippocratic AI has raised $120M in total — $115M more than Predible Health's $5M.

Predible Health has 6 years more market experience, having been founded in 2017 compared to Hippocratic AI's 2023 founding. In terms of growth stage, Hippocratic AI is at Series B while Predible Health is at Series A — a meaningful difference for investors evaluating risk and upside.

Hippocratic AI operates out of 🇺🇸 United States while Predible Health is based in 🇮🇳 India, giving each a distinct home-market advantage. On Awaira's 0–100 composite score, Hippocratic AI leads with a score of 65, reflecting stronger overall fundamentals across valuation, funding, and growth signals.

Metrics Comparison

MetricHippocratic AIPredible Health
💰Valuation
N/A
N/A
📈Total Funding
$120MWINS
$5M
📅Founded
2023WINS
2017
🚀Stage
Series B
Series A
👥Employees
50-200
10-50
🌍Country
United States
India
🏷️Category
AI Healthcare
AI Healthcare
Awaira Score
65WINS
50

Key Differences

📈

Funding gap: Hippocratic AI has raised $115M more ($120M vs $5M)

📅

Market experience: Predible Health has 6 years more (founded 2017 vs 2023)

🚀

Growth stage: Hippocratic AI is at Series B vs Predible Health at Series A

👥

Team size: Hippocratic AI has 50-200 employees vs Predible Health's 10-50

🌍

Market base: 🇺🇸 Hippocratic AI (United States) vs 🇮🇳 Predible Health (India)

⚔️

Direct competitors: Both operate in the AI Healthcare market segment

Awaira Score: Hippocratic AI scores 65/100 vs Predible Health's 50/100

Which Should You Choose?

Use these signals to make the right call

H

Choose Hippocratic AI if…

Top Pick
  • Higher Awaira Score — 65/100 vs 50/100
  • Stronger investor backing — raised $120M
  • United States-based for regional compliance or proximity
  • Hippocratic AI develops a safety-focused AI platform designed to address the global shortage of healthcare professionals by deploying AI agents that perform patient-facing healthcare communication tasks including care navigation, medication adherence outreach, chronic disease monitoring, and post-discharge follow-up
P

Choose Predible Health if…

  • More market experience — founded in 2017
  • India-based for regional compliance or proximity
  • Predible Health develops AI software for radiology and medical imaging analysis, with a focus on automated CT scan interpretation for lung nodule detection, COVID-19 assessment, and liver segmentation

Users Also Compare

FAQ — Hippocratic AI vs Predible Health

Is Hippocratic AI bigger than Predible Health?
Neither company has publicly disclosed a valuation, making a definitive size comparison difficult. Hippocratic AI employs 50-200 people, while Predible Health has 10-50 employees.
Which company raised more funding — Hippocratic AI or Predible Health?
Hippocratic AI has raised more in total funding at $120M, compared to Predible Health's $5M — a gap of $115M.
Which company has a higher Awaira Score?
Hippocratic AI holds the higher Awaira Score at 65/100, compared to Predible Health's 50/100. The Awaira Score is a composite metric factoring in valuation, funding, stage, team size, and market presence — a 15-point gap that reflects meaningful differences in scale or traction.
Who founded Hippocratic AI vs Predible Health?
Hippocratic AI was founded by Munjal Shah in 2023. Predible Health was founded by Sanjoy Paul in 2017. Visit each company's profile on Awaira for a full founder biography.
What does Hippocratic AI do vs Predible Health?
Hippocratic AI: Hippocratic AI develops a safety-focused AI platform designed to address the global shortage of healthcare professionals by deploying AI agents that perform patient-facing healthcare communication tasks including care navigation, medication adherence outreach, chronic disease monitoring, and post-discharge follow-up. The platform is built around a healthcare-specific large language model with extensive safety evaluation against clinical benchmarks.\n\nThe company raised approximately 120 million USD in early rounds and has established partnerships with health systems and payers focused on reducing care gaps and improving patient engagement at scale. Hippocratic positions its AI as augmenting the healthcare workforce rather than replacing clinicians, targeting the vast volume of lower-acuity patient interactions that do not require physician judgment.\n\nThe healthcare staffing shortage is a structural problem projected to worsen over the next decade, creating durable demand for AI solutions that extend the capacity of existing clinical teams. Hippocratic AI competes with ambient clinical AI companies and general-purpose AI assistant platforms, but its narrow vertical focus on patient-facing healthcare communication and its safety-first design philosophy position it to navigate the regulatory and liability landscape that general AI platforms are less equipped to manage. Predible Health: Predible Health develops AI software for radiology and medical imaging analysis, with a focus on automated CT scan interpretation for lung nodule detection, COVID-19 assessment, and liver segmentation. The platform integrates with radiology information systems and PACS to provide AI-assisted second reads and quantitative measurements that reduce reporting time and flag critical findings for urgent review.\n\nThe company raised approximately $5M in Series A funding and has established clinical partnerships with hospital networks and diagnostic imaging centers across India. Predible Health received significant validation through its COVID-19 CT analysis tool, which was deployed during the pandemic to help overwhelmed radiology departments manage surge volumes.\n\nRadiology AI represents one of the most commercially mature segments of medical AI globally, with clear clinical workflows, measurable radiologist productivity benefits, and established reimbursement pathways emerging in developed markets. Predible Health's India-focused deployments position it as a domestic alternative to global radiology AI companies, with the advantage of deep integration knowledge in Indian hospital IT environments.
Which company was founded first?
Predible Health was founded first in 2017, giving it 6 years of additional market experience. Hippocratic AI was founded later in 2023. In AI, even a year or two of head start can translate into significantly more training data, customer relationships, and institutional knowledge.
Which company has more employees?
Hippocratic AI has approximately 50-200 employees, while Predible Health has approximately 10-50. A larger team often signals higher revenue or venture backing, but in AI, smaller teams are increasingly capable of building at scale.
Are Hippocratic AI and Predible Health competitors?
Yes, Hippocratic AI and Predible Health are direct competitors — both operate in the AI Healthcare space and likely target overlapping customer segments. This comparison is especially relevant for buyers evaluating both platforms.